Gram-Negative Infections and the Emergence of Resistance: Is One Drug Enough?
Track:
Education Sessions (CE)
Program Code: 252-L01
Date: Tuesday, December 4, 2012
Time: 10:00 AM to 11:00 AM EST
Location:
Lagoon K, Level 2, South Convention Center
PRESENTER:
Click the plus sign to see more detailed information about each speaker.
Elizabeth Hirsch, PharmD, BCPS, Assistant Professor, Northeastern University
Betsy Hirsch, PharmD, BCPS, is an Assistant Professor in the Department of Pharmacy Practice at Northeastern University School of Pharmacy in Boston, MA. Dr. Hirsch received her B.S. in Health Sciences and PharmD from Creighton University in Omaha, NE. She then completed a PGY1 Pharmacy Practice Residency at St. Lukes Episcopal Hospital in Houston, TX, along with an Infectious Diseases Pharmacotherapy Fellowship program in conjunction with the University of Houston College of Pharmacy and St. Lukes Episcopal Hospital. Prior to joining Northeastern, she spent a year as Research Assistant Professor at the University of Houston. Dr. Hirsch's primary research interests include antimicrobial pharmacokinetics / pharmacodynamics, mechanisms of bacterial resistance, and clinical outcomes following Gram-negative infections.
PROGRAM CHAIR:
Elizabeth Hirsch
Discuss key concepts and recent literature on new agents in development for Gram-negative infections.
Examine the current state of resistance in Gram-negative pathogens.
Summarize the relevant literature on effective combinations for drug-resistant bacteria.